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INTRODUCTION: Wnt/β-catenin signaling activation has been reported only during the late steps of Barrett’s esophagus
(BE) neoplastic progression, but not in BE metaplasia, based on the absence of nuclear β-catenin. However, β-catenin
transcriptional activity has been recorded in absence of robust nuclear accumulation. Thus, we aimed to investigate the
Wnt/β-catenin signaling in nondysplastic BE. METHODS: Esophageal tissues from healthy and BE patients without
dysplasia were analyzed for Wnt target gene expression by quantitative reverse transcription polymerase chain reaction
(qRT-PCR) and immunohistochemistry. Esophageal squamous (EPC1-& EPC2-hTERT), BE metaplastic (CP-A), and
adenocarcinoma (OE33) cell lines were characterized forWnt activation by qRT-PCR,Western blot, and luciferase assay.
Wnt activity regulation was examined by using recombinant Wnt3a and Dickkopf-1 (Dkk1) as well as Dkk1 short
interfering RNA. RESULTS:Wnt target genes (AXIN2, c-MYC, Cyclin D1,Dkk1) andWnt3a were significantly upregulated
in nondysplastic BE comparedwith squamousmucosa. Elevated levels of dephosphorylated β-catenin were detected in
nondysplastic BE. Nuclear active β-catenin and TOPflash activity were increased in CP-A and OE33 cells compared with
squamous cells. Wnt3a-mediated β-catenin signaling activation was abolished by Dkk1 in CP-A cells. TOPFlash activity
was elevated followingDkk1 silencing in CP-A but not in OE33 cells. Dysplastic and esophageal adenocarcinoma tissues
demonstrated further Dkk1 and AXIN2 overexpression. CONCLUSIONS: Despite the absence of robust nuclear
accumulation,β-catenin is transcriptionally active in nondysplastic BE.Dkk1overexpression regulatesβ-catenin signaling
in BE metaplastic but not in adenocarcinoma cells, suggesting that early perturbation of Dkk1-mediated signaling
suppression may contribute to BE malignant transformation.
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Barrett’s esophagus (BE) is the metaplastic replacement of the normal
esophageal squamous epithelium with an intestinal-type columnar
epithelium and is clinically important, as it predisposes to esophageal
adenocarcinoma (EAC), a malignancy with rapidly increasing
incidence and dismal 5-year survival rate [1,2]. The molecular
mechanisms underlying the pathogenesis of BE formation remain
elusive. The current paradigm of BE formation requires gastric acid
and bile reflux to activate signaling pathways, transcriptional factors,
and inflammatory processes, which, in turn, regulate proliferation and
differentiation and may facilitate the replacement of reflux-damaged
squamous cells through columnar metaplasia [3]. In particular,
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master regulator of intestinal cell phenotype, is currently believed to
drive the BE formation, yet CDX2 alone is not sufficient to induce
metaplasia [3,4]. Thus, activation of alternative pathways involved in
the development or maintenance of intestinal-type mucosa may
predispose to Barrett’s metaplasia.
Wnt/β-catenin signaling pathway is required for early gut
morphogenesis and maintenance of intestinal phenotype [5].
Activation of the canonical Wnt/β-catenin signaling is marked by
nuclear translocation of dephosphorylated β-catenin in the presence
of secreted Wnt glycoproteins or different mitotic signals. β-Catenin
is involved in two independent processes: cell–cell adhesion and signal
transduction [6]. In the absence of Wnt signal, β-catenin is
sequestered in a "destruction complex," consisting of glycogen
synthase kinase-3β, casein kinase 1, adenomatous polyposis coli
(APC), and Axin [7]. This complex forces β-catenin’s phosphoryla-
tion, which then is subjected to subsequent degradation by the
ubiquitin-proteasome system [7]. Upon Wnt signal, β-catenin is
dephosphorylated and accumulates in the cytoplasm and subsequent-
ly to the nucleus, where it binds to members of TCF/LEF-1
transcription factors and initiates transcription of target genes (Cyclin
D1, Axin2, c-MYC, Dkk1, etc.) [8].
Aberrant activation of the Wnt/β-catenin signaling has been
reported during the late steps of BE neoplastic progression but not in
BE metaplasia [9–11]. However, in BE dysplasia and EAC, the
common mutations of the pathway’s components found in other
cancers, such as β-catenin and APC, are not frequently detected [12].
Instead, the progression of BE dysplasia to EAC is marked by
changes, such as loss of the negative regulators of the pathway, Wnt
inhibitory factor 1 and secreted frizzled receptor proteins, as well as
induction of Wnt-2 expression, which are expected to increase
signaling along the Wnt axis [10,13,14]. In contrast to dysplasia and
EAC, in nondysplastic BE, the Wnt/β-catenin signaling appears
inactivated because of absence of robust nuclear β-catenin accumu-
lation [9]. However, β-catenin transcriptional activity has been
reported also in the absence of robust nuclear accumulation [15],
whereas the notion that Wnt/β-catenin signaling may contribute to
BE formation has been supported already by various observations.
Increased levels of the β-catenin target genes, Cyclin D1 and c-myc,
have been found in BE before dysplastic progression [16,17], whereas
β-catenin signaling has been associated with transcription of several
intestinal markers in BE, such as Sox9 and CDX1 [18,19]. Recently,
activation of Wnt signaling has been reported efficient for
intestinalization of human esophageal keratinocytes in vitro [20].
Therefore, whether Wnt/β-catenin signaling is activated during the
early onset of Barrett’s metaplasia is an attractive hypothesis that has
not been fully addressed yet.
Dickkopf-1 (Dkk1) is a secreted glycoprotein that blocks Wnt
signaling by binding to the extracellular domain of the Wnt
co-receptor LRP5/6, thus preventing the Wnt-induced stabilization
of β-catenin [21]. Furthermore, Dkk1 has been reported to be a
downstream target gene of β-catenin signaling and to exaggerate its
inhibition in a negative feedback loop mechanism [22,23].
Intriguingly, unlike other Wnt suppressors, Dkk1 is found to be
upregulated in BE dysplasia and EAC compared with BE metaplasia
[24]. Previous studies have reported Dkk1 overexpression in human
esophageal reflux esophagitis compared with healthy mucosa [25,26].
Taken together, these observations suggest a crucial role for Dkk1 in
regulating esophageal biology.In the present study, we investigated the levels of Wnt/β-catenin
signaling activation in nondysplastic BE. By analyzing esophageal
tissues and esophageal cell lines, we report a modest level of Wnt/
β-catenin signaling activation in BE metaplasia beyond robust nuclear
β-catenin accumulation. In addition, we demonstrate a high
sensitivity of BE metaplastic cells to increase β-catenin signaling
upon Wnt signals in vitro. We further attribute the moderate level of
signaling activation in BE to the subsequent increased levels of the
Wnt target gene, Dkk1, which regulates the signaling in a negative
feedback loop. Finally, we demonstrate the inability of endogenous
Dkk1 to regulate β-catenin signaling in adenocarcinoma cells,
signifying that early perturbation of Dkk1-mediated signaling
suppression may lead to esophageal tumorigenesis.Materials and Methods
Human Esophageal Specimens
Human esophageal biopsy specimens were collected from patients
18 years or older undergoing endoscopy for BE and healthy
individuals undergoing endoscopy for nonesophageal indications.
Biopsies from patients with BE were obtained from the site of
Barrett’s lesion and the proximal squamous mucosa. Following
pathological assessment, samples from patients with Barrett’s
dysplasia, EAC, or active esophagitis were excluded. Patients with
previous history of eosinophilic esophagitis, Barrett’s associated
dysplasia, EAC, or any other malignancy were also excluded. Full
esophageal thickness specimens were obtained after surgical esoph-
agectomy from patients with EAC. Studies were approved by the
Human Research Review Committee of the Medical College of
Wisconsin, and study participants gave written informed consent
prior to their studies.
Cell Culture
Human squamous esophageal telomerase-immortalized cells
EPC1-hTERT (EPC1) and EPC2-hTERT (EPC2) were the
generous gifts of Dr. Hiroshi Nakagawa, Gastroenterology Division,
University of Pennsylvania (Philadelphia, PA), and were grown as
previously described [26]. A nondysplastic columnar cell line derived
from BE (CP-A) was obtained from the American Type Culture
Collection (Rockville, MD) and was adapted to MCDB-153 growth
medium (Sigma) supplemented according to the manufacturer’s
protocol. Poorly differentiated esophageal adenocarcinoma cancer
cells (OE33) were obtained from Sigma Aldrich and were maintained
in complete growth medium (RPMI-1640 supplemented with 2 mM
L-glutamine, 10% bovine serum, and 1% gentamycin). All cell lines
were maintained in monolayer culture at 37°C in humidified air with
5% CO2 in growth medium until they were 80% to 90% confluent.
Reagents and Antibodies
Recombinant human Wnt3a (rhWnt3a/200 ng/ml), recombinant
human Dkk1 (rhDkk1/500 ng/ml), and neutralizing anti-Dkk1
monoclonal antibody (anti-Dkk1 Ab/10 μg/ml) were obtained from
R&D Systems Inc. (Minneapolis, MN). Human IgG (10 μg/ml) was
from Innovative Research (Novi, MI). Antibodies against Dkk1 and
AXIN2 were obtained from Abcam (Cambridge, MA); active
β-catenin (ABC) was from Millipore (Billerica, MA), total β-catenin,
cytokeratin 4, cytokeratin 8/18, and GAPDH were obtained from
Cell Signaling Technology (Danvers, MA); and horseradish perox-
idase secondary antibodies were obtained from Santa Cruz. β-Actin
Table 1. Sequence of Primers Used for RT-PCR Analysis
Gene Name Official Symbol Gene ID Sequence
β-actin ACTB NM_001101.3 Forward: 5'-CAC TCT TCC AGC CTT CCT TC-3'
Reverse: 5'-GGT GTA ACG CAA CTA AGT CAT AG-3'
Cyclin D1 CCND1 NM_053056.2 Forward: 5'-CAT CTA CAC CGA CAA CTC CAT C-3'
Reverse: 5'-TCT GGC ATT TTG GAG AGG AGG-3'
Axin2 AXIN2 NM_004655.3 Forward: 5'-TAC CGG AGG ATG CTG AAG GC-3’
Reverse: 5'-CCA CTG GCC GAT TCT TCC TT-3'
Dickkopf-1 DKK1 NM_012242.2 Forward: 5'-AGC GTT GTT ACT GTG GAG AAG-3'
Reverse: 5'-GTG TGA AGC CTA GAA GAA TTA CTG-3'
c-MYC MYC NM_002467 Forward: 5’-ACC AGA GAA ACC TAA CAG TGC-3’
Reverse: 5’-CTC TTT CAT TTC GGC CAG TTC-3’
Wnt3a WNT3A NM_033131 Forward: 5'-CCA TCC TCT GCC TCA AAT TC-3’
Reverse: 5’-TGG ACA GTG GAT ATA GCA GCA-3’
CDX-2 CDX2 NM_001265 Forward: 5’-GGA GCT GGA GAA GGA GTT TC-3’
Reverse: 5’-TTT CCT CTC CTT TGC TCT GC-3’
SOX-9 SOX9 NM_000346 Forward: 5’-GAC CAG TAC CCG CAC TT-3’
Reverse: 5’-TTC ACC GAC TTC CTC CG-3’
BMP-4 BMP4 NM_001202 Forward: 5’-TTG AGT ATC CTG AGC GCC CG-3’
Reverse: 5’-GTT TAT ACG GTG GAA GCC CC-3’
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were obtained from Sigma (St. Louis, MO) unless otherwise specified.
RNA Isolation and Real-Time Quantitative Polymerase Chain
Reaction (PCR) Analysis
RNA was isolated from biopsies and cell cultures using Arcturus
PicoPure RNA (Life Technologies, Grand Island, NY) and Qiagen
RNeasy Kit (Qiagen, Valencia, CA), respectively. One microgram of
total RNA was used for cDNA synthesis using the Bio-Rad’s iScript
cDNA synthesis Kit according to the manufacturer’s protocol
(Bio-Rad, Hercules, CA). Real-time PCR was performed with
Bio-Rad’s SsoFast EvaGreen Supermix, with 250-nM primer
concentration, and 1 μl of cDNA per 20-μl reaction. Normalized
gene expression was analyzed with Bio-Rad’s CFX software. The
primers used for AXIN2, Cyclin D1, Dkk1, C-myc, Wnt3a, CDX2,
BMP4, and SOX9 are listed in Table 1.
Western Blot Analysis
Total cell extracts were prepared by scraping the cells into RIPA
buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.25%
sodium deoxycholate, 1% NP-40, 10 mM Na3VO4, 40 mM
5-glycerophosphate, 1 mM PMS, 20 mM NaF, protease inhibitor
cocktail]. Equal amounts of protein were separated by SDS-PAGE
and transferred to nitrocellulose membranes as described previously
[26]. The membranes were blocked for 1 hour at room temperature
in 3% (w/v) BSA and 3% (w/v) nonfat dry milk in Tris-buffered
saline (50 mM Tris-HCl, 150 mM NaCl, pH 7.4) containing 0.1%
(v/v) Tween 20, and then they were incubated with a specific primary
antibody at 4°C overnight as specified. Detection of bound antibody was
performed using a peroxidase-conjugated secondary goat anti-rabbit
antibody or goat anti-mouse antibody and ECL chemiluminescence
detection kit [Super Signal West Pico (Thermo Scientific)].
Immunohistochemistry and immunofluoresence staining was
performed as described previously [26].
Luciferase Reporter Assay
Cells in 60% to 70% confluence were transfected for 48 hours with
DNA plasmids of β-catenin-LEF/TCF-sensitive (TOP-flash) or
β-catenin-LEF/TCF insensitive (FOP-flash) reporter vectors
(Addgene, Cambridge, MA) using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions. Thefollowing amounts of plasmids were used per well of a 24-well plate: 1
μg and 0.5 μg of TOPflash as well as 1 μg and 0.5 μg of FOPflash for
CP-A and OE33 cells, respectively. phRL-TK plasmid (Promega,
Madison, WI) was co-transfected as control for transfection
efficiency. Forty-eight hours posttransfection, experimentation
followed as indicated. Reporter assay was performed using dual
luciferase reporter system (Promega). Luciferase activity was measured
via GLOMAX 20/20 Luminometer (Promega). Values for each
reporter were normalized to phRL-TK values.
Dkk1 Gene Silencing
CP-A cells (60%-70% confluence) were transfected with
predesigned short interfering RNA (siRNA), targeting human
Dkk-1 [ON-TARGETplus SMARTpool, Human DKK1 (22943),
Dharmacon, Lafayette, CO], and a control negative siRNA, targeting
a sequence not sharing homology with the human genome (ON-
TARGETplus Non-targeting siRNA, Dharmacon), using
DharmaFECT transfection reagent as per manufacturer’s protocol
(Dharmacon). The ratio of siRNA to the DharmaFECT reagent was
25 nM siRNA to 1.5 μl of transfection reagent.
Statistical Analysis
IBM SPSS-Statistics-19 statistical analysis software was used. All
experiments were performed in triplicates, and data were expressed as
mean ± SEM. Significant differences were evaluated by Student’s t
tests or Mann-Whitney, as noted. P values less than .05 were
considered statistically significant.
Results
Expression of Wnt-Signaling Target Genes in
Barrett’s Metaplasia
We quantitatively compared mRNA expression of the major
Wnt-signaling target genes, AXIN2, Dkk1, Cyclin D1, and c-Myc,
between squamous esophageal mucosa and nondysplastic Barrett’s
mucosa in patients with BE and healthy controls. Real-time PCR
analysis demonstrated that all Wnt target genes were significantly
overexpressed in Barrett’s metaplastic mucosa compared with the
corresponding paired squamous mucosa in Barrett’s patients and
healthy controls (P b .05, Mann-Whitney test) (Figure 1, A–D). No
significant differences were observed in the gene expression between
Figure 1.Wnt-signaling target genes expression in Barrett’s metaplasia: (A-D) Box plots of qRT-PCR data for mRNA expression of theWnt
target genes AXIN2, Dkk1, Cyclin D1, and c-MYC in squamous esophageal mucosa (SQ) and metaplastic mucosa (BE) of healthy
individuals (n= 10) and Barrett’s patients (n= 15) (normalized with β-actin). Box plots of (E)Wnt3a and (F) CDX2mRNA expression in the
same samples as described above. (G) Immunohistochemistry for AXIN2, Dkk1, c-Myc, and Cyclin D1 protein expression in Barrett’s
metaplasia as opposed to squamous mucosa (Supplementary Figure 1). (P values are provided, Mann-Whitney test).
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Figure 1. (continued.)
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Barrett’s patients. Gene expression of Wnt3a, the major canonical
Wnt signal, was higher in Barrett’s metaplasia compared with the
squamous epithelium (Figure 1E). Confirmatory of BE lesion,
CDX-2 expression was significantly higher in Barrett’s metaplasia
tissues as opposed to corresponding squamous tissues (Fig. 1F).
Immunohistochemistry further confirmed high levels of AXIN2,
Dkk1, c-Myc, and Cyclin D1 protein expression in the metaplastic
columnar epithelial cells of Barrett’s mucosa (Figure 1G). AXIN2
was expressed in cytoplasm, whereas Dkk1, c-Myc, and Cyclin D1
were detected in nucleus. Contrary to BE, expression of AXIN2 and
Dkk1 proteins in squamous mucosa was limited to the basal mucosal
layer, whereas gastric mucosa demonstrated a weak expression of
AXIN2 (Supplementary Figure 1). In all, this positive expression of
Wnt target genes suggests activation of Wnt/β-catenin signaling in
Barrett metaplasia.
Expression of ABC in Barrett’s Metaplasia
To further evaluate the activation of Wnt/β-catenin signaling in
BE, we analyzed the expression levels and the intracellular localization
of the transcriptionally ABC in BE metaplasia and compared with
those of squamous esophageal epithelium. We emphasized on the
amounts of the active form of β-catenin (ABC) rather than total
amounts of β-catenin. ABC is the signaling isoform of β-catenin,
which is dephosphorylated at Ser37 or Thr4, and is not susceptible to
either ubiquitination or degradation [27,28]. Using a specific
antibody against the ABC, immunofluoresence staining revealed
elevated levels of nuclear (arrowheads) and perinuclear (arrows) ABC
in nondysplastic BE tissue, as opposed to squamous epithelium, in
which ABC was exclusively localized at cellular junctions (Figure 2A).
Further quantification of ABC via Western blotting in biopsies from
BE patients and healthy controls demonstrated markedly elevated
ABC expression in Barrett’s metaplastic mucosa compared with the
corresponding paired squamous mucosa (Figure 2B). Of note,Barrett’s tissues demonstrated also a mobility shift of the protein in
SDS-PAGE at a slightly higher molecular weight of 92 kDa, possibly
as a result of an extra phosphorylation. The increased amounts of
ABC along with its nuclear localization cells are strong indicators of
β-catenin signaling transcriptional activity in Barrett’s metaplasia.
Wnt/β-Catenin Signaling in Esophageal Cell Lines
Next, we determined the level of Wnt/β-catenin signaling
activation in a panel of resting esophageal cell lines representing
squamous esophageal epithelium (EPC1/EPC2), BE metaplasia
(CP-A), and esophageal adenocarcinoma (OE33). All cell lines were
validated by expression of cytokeratins and typical markers of BE
intestinal metaplasia (Supplementary Figure 2, A and B). Resting
CP-A and OE33 cells demonstrated increased expression of Wnt
target genes (Figure 3A) along with elevated levels of TOP-flash
activity (Figure 3B), compared with EPC1 and EPC2 squamous
epithelial cells, as shown by real-time PCR and luciferase assay,
respectively. Notably, there was no appreciable β-catenin transcrip-
tional activity detected in EPC1 and EPC2 cells. In contrast, the
colorectal cancer cell line Caco2, which served as positive control,
demonstrated high TOP-flash activity.
As shown by Western blotting in resting cells, the levels of ABC
were significantly higher in CP-A and OE33 cell lines compared with
squamous cell lines (Figure 3C). Of note, CP-A and OE33 cells also
demonstrated a mobility shift of the protein in SDS-PAGE at a
slightly higher molecular weight of 92 kDa. The intracellular
localizations of the total β-catenin and ABC were further evaluated
by immunofluorescence microscopy. In all cell lines, ABC was stained
predominantly in nucleus, whereas polyclonal antibody against the
C-terminus detected the total β-catenin in cellular membranes and
adherent junctions (Figure 3D). However, in CP-A cells, the amount
of ABC was markedly increased in the nucleus compared with
squamous cell lines. In OE33 cells, the ABC was exclusively detected
in the nucleus.
ABC DAPIH&E Merge
DAPIH&E ABC Merge
SQ
BE
A
B Healthy control Barrett patient #1 Barrett patient #2
ABC
β-actin
92 kDa
40 kDa
Figure 2. ABC expression in Barrett’s metaplasia: (A) Immunofluorescence microscopy for expression and localization of ABC protein in
squamous esophageal mucosa (SQ) and nondysplastic Barrett’smetaplasia (BE). Arrowheads depict nuclear localization, whereas arrows
show perinuclear cytoplasmic localization. Representative tissue staining of at least three different tissues is presented. (B) Western blot
analysis of ABC protein expression in representative human esophageal biopsies. Significantly elevated amounts of ABC were
demonstrated in Barrett’s metaplastic mucosa compared with the corresponding paired squamous mucosa.
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transcriptional activity in resting BE metaplastic epithelial cells in vitro as
opposed to squamous epithelial cells, whereas BE-associated adenocarci-
noma cells demonstrate even higher level of signaling activation.
Wnt Signal Activates β-Catenin Signaling in CP-A Cells
The overexpression of Wnt3a mRNA in BE metaplasia tissues as
shown above prompted us to examine next whether BE metaplastic
cells respond to canonical Wnt signals by activating β-catenin
mediated transcription. Using different concentrations of rhWnt3a,
we stimulated CP-A cells for 24 hours. As shown by luciferase assay,
rhWnt3a significantly increased TOP-flash activity in a concentra-
tion-dependent manner (Figure 4A). Lithium chloride, the chemical
activator of β-catenin signaling, could significantly increase TOP-
flash activity in CP-A cells and served as positive control. Western
blotting showed that continuous stimulation of CP-A cells with
rhWnt3a 200 ng/ml for 24 hours resulted in stabilization of totalβ-catenin and increased AXIN2 protein expression (Figure 4B).
Immunofluorescence microscopy further verified the nuclear trans-
location of β-catenin in CP-A cells after rhWnt3a stimulation
(arrows; Figure 4C). These results underscore the sensitivity of BE
metaplastic cells to activate β-catenin signaling upon Wnt3a signal.
Rapid and Transient β-Catenin Activation by Wnt3a in
CP-A Cells
We questioned next whether Wnt3a activates β-catenin transcrip-
tion in a time-dependent fashion. As shown by luciferase assay of
CP-A cells, TOP-flash activation reached a peak 3 hours after the
incubation with rhWnt3a (200 ng/ml) and then gradually decreased
after 6, 12, and 24 hours (Figure 5A). This transient fashion of
TOPflash activation in CP-A cells upon Wnt3a stimulation was
further confirmed by real-time PCR for the Wnt target genes AXIN2
and Dkk1. As shown in Figure 5B, transcription of AXIN2 and Dkk1
mRNA reached a peak 6 hours after Wnt3a incubation and markedly
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EPC1 cells is presented. (C) Western blot analysis of ABC and Dkk1 protein expression in all cell lines at resting conditions. β-Actin serves
as a loading control. (D) Immunofluorescence microscopy for colocalization of total β-catenin (Ab against C-terminus) and ABC protein in
all cell lines at resting conditions. ABC was predominantly nuclear, whereas total β-catenin was localized in the membrane and adherent
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continuous Wnt3a stimulation, the gene levels of both target genes
returned back to the base levels. These findings support the notion
that canonical Wnt3a signal could rapidly and in a transient fashion
activate β-catenin signaling in BE metaplastic epithelial cells.
Dkk1 SuppressesWnt3a-Inducedβ-Catenin Signaling in CP-ACells
Given that Dkk1 counteracts the Wnt3a binding to LRP5/6
receptor [22], we questioned next whether the subsequent Dkk1upregulation following Wnt3a-induced β-catenin signaling activation
could explain its transient character. Thus, CP-A cells were incubated
with rhWnt3a in the presence or absence of rhDkk1. As shown in
Figure 6A, rhDkk1 abolished the ability of rhWnt3a to increase
TOPflash activity and AXIN2 transcription, suggesting that excess
amounts of extracellular Dkk1 suppress the Wnt-axis in BE.
Furthermore, following Dkk1 siRNA-mediated gene knockdown
in resting CP-A cells (over 75% knockdown), a significant increase in
TOPflash activity was observed (Figure 6B). This observation implies
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β-catenin signaling activation in CP-A cells. To further address
whether Dkk1 transcriptional activation as the result of Wnt3a-in-
duced signaling could suppress further activation, we applied
rhWnt3a to CP-A cells after sufficient siRNA-mediated Dkk1 gene
silencing. As shown by real-time PCR, the AXIN2 mRNA levels were
significantly increased following Wnt3a incubation for 24 and 48
hours in the CP-A cells, which underwent Dkk1 silencing compared
with the wild-type cells (Figure 6C). These findings suggest that
Dkk1 upregulation follows in response to β-catenin signaling
activation to suppress signaling in an autocrine negative feedback
loop. BE metaplastic cells, which are unable to respond toWnt3a-induced signaling activation by upregulating Dkk1, may be
subject to constitutive β-catenin transcriptional activation.
Dkk1 Overexpression in BE-Associated Adenocarcinoma
To address the significance of these observations in BE neoplastic
progression, we investigated next the AXIN2 and Dkk1 expression in
esophageal tissues with BE-associated dysplasia and carcinoma.
Immunohistochemistry in dysplastic and carcinoma tissues, which
were obtained from patients with EAC undergoing esophagectomy,
demonstrated markedly elevated protein expression of both major
Wnt targets AXIN2 and Dkk1 (Figure 7, A and B). These expression
patterns support further Wnt signaling in those tissues and come in
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signaling during the neoplastic progression of Barrett’s metaplasia [9].
Given the inhibitory effects of Dkk1 on β-catenin signaling activity
in BE metaplasia, we questioned whether Dkk1 exerts similar
signaling suppression in BE-associated adenocarcinoma. Therefore,
we analyzed next the levels of β-catenin signaling in OE33 cells
following Dkk1 gene silencing (Figure 7C). As shown by luciferase
assay and real-time PCR, the Dkk1 knockdown had no effect on the
baseline TOPflash activity in OE33 (Figure 7D), suggesting the
inability of Dkk1 to autoregulate the levels of β-catenin signaling in
OE33 cells as it did in CP-A cells. Taken together, these findings
suggest that the upregulation of Dkk1 in EAC is the result of the
aberrant activation of the Wnt/β-catenin signaling, without, however,
being able to regulate the signaling levels like in its precursor lesion of
Barrett metaplasia.
Discussion
In this study, we report a moderate level of Wnt/β-catenin signaling
activation, beyond robust nuclear β-catenin, in nondysplastic BE and
provide evidence that Dkk1 overexpression suppresses Wnt axis in BE
metaplastic cells but not in adenocarcinoma cells. By analyzing
human esophageal tissues, we showed significant upregulation of the
major Wnt target genes along with elevated levels of perinuclear and
nuclear localization of ABC in nondysplastic BE as opposed to
squamous esophageal mucosa. In vitro, Wnt/β-catenin signaling
activation was confirmed in BE metaplastic (CP-A) and adenocar-
cinoma (OE33) cell lines by increased TOPflash activity, elevated
levels of nuclear ABC, and overexpression of Wnt target genes
compared with squamous epithelial cells. Recombinant Wnt3a
activated β-catenin signaling in CP-A cells, an effect that wassignificantly attenuated by recombinant Dkk1. Reversely, Dkk1
knockdown increased TOPflash activity and AXIN2 gene expression
in these cells, underlying the Dkk1-mediated suppression of Wnt
axis. Furthermore, we have shown elevated AXIN2 and Dkk1 protein
expression in BE-associated dysplastic and cancerous tissues, ratifying
the aberrant Wnt activation during BE carcinogenesis [9–11].
However, contrary to CP-A cells, Dkk1 knockdown in OE33 cells
did not alter TOPflash activity, underscoring the possible inability of
Dkk1 to suppress Wnt axis in cancer cells. Together, these findings
support the role of Wnt signaling in the development of BE
metaplasia and define Dkk1 as a potential key suppressor toward
neoplastic progression.
To date, the canonical Wnt/β-catenin signaling is believed to be
inactivated in BE metaplasia based on the absence of robust nuclear
β-catenin in patient biopsies [9]. However, our study clearly points to
an elevated β-catenin activity in BE metaplasia, compared with
normal squamous epithelium, as confirmed by Wnt target gene
overexpression and increased levels of dephosphorylated ABC. This
discrepancy can partly be explained by the latest developments in our
understanding on how β-catenin functions. Undoubtedly, β-catenin
nuclear accumulation is a clear hallmark of canonical Wnt signaling
activation [29]. However, β-catenin accumulation alone and nuclear
localization are not indicative of transcriptional activity [30]. It is now
appreciated that β-catenin signaling can be observed in the absence of
robust nuclear accumulation and that the signaling form of β-catenin
can be a minor, nuclear-enriched population of the total cytosolic
pool of β-catenin [15]. As such, β-catenin levels alone appear to be
insufficient to explain possible Wnt signal, whereas the intracellular
localization and the posttranslational modifications (phosphoryla-
tions) of β-catenin appear to be more important in dictating signaling
function. Characteristically, β-catenin, which remains unphosphory-
lated at glycogen synthase kinase residues 33, 37, and 41, is
intrinsically more active than β-catenin, which gets phosphorylated at
these residues [28]. Thus, using a specific antibody detecting the
dephosphorylated (Ser 37002FThr 41) ABC, we verified higher
β-catenin activity in BE compared with squamous mucosa.
Furthermore, the Wnt target gene overexpression, such as AXIN2,
as reported here, is a more sensitive indicator of even low levels of
signaling activation [31]. Our approach in detecting β-catenin activity
as opposed to immunohistochemistry alone revealed a modest and
not a high signaling activation in metaplasia. This modest activity
goes along with previous speculations driven by the upregulation of
β-catenin transcriptional regulators in BE despite the absence of robust
nuclear β-catenin [11,32].On the other hand, in dysplastic and cancerous
tissues, elevated levels of nuclear β-catenin correlated with higher Wnt
signaling activation [11], signifying that robust nuclear β-catenin may be
addressed only in aberrant signaling activation.
The trigger of the β-catenin activation in BE remains unclear.
Given the signaling inactivation in squamous epithelium of the adult
esophagus [9,33] and the fact that BE develops in response to severe
gastroesophageal reflux disease, the trigger should be sought in the
reflux-associated mucosal injury. Indeed, refluxate components and
inflammatory mediators, such as tumor necrosis factor–α, have been
reported to activate Wnt signaling in vitro [32,34]. Another possible
scenario is that the enhanced β-catenin activity in BE is dictated by
Wnt-independent phosphorylation of β-catenin. In fact, β-catenin
tyrosine (Y) phosphorylation by active receptor tyrosine kinases
affects Wnt signaling [35–37], and enhanced AKT-mediated
β-catenin activation has already been reported in BE-associated
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CP-A cells demonstrated a mobility shift of the ABC protein in
SDS-PAGE at slightly higher molecular weight of 92 kDa, indicating
that a portion of the dephosphorylated ABC can carry extra activating
phosphorylation. Nevertheless, our current findings mainly support
activation via Wnts. The Wnt3a gene overexpression in metaplastic
BE along with the high sensitivity of CP-A cells to increase β-catenin
transcriptional activity uponWnt3a stimulation allows us to speculate
that elevated amounts of canonical Wnts within the microenviroment
of BE metaplasia dictate β-catenin activity. In line with this notion,
differential expression of Wnt ligands has already been suggested insquamous epithelium [38], whereas the reflux-associated expression of the
Wnt-antagonist Dkk1may prevent canonicalWnt signaling as a response
to constitutive increase of Wnt signals during reflux esophagitis [26].
These scenarios summarize a complex mechanism behind the β-catenin
activity in BE, which still merits further elucidation.
The absence of higher signaling activation in BE implies the
existence of a compensative mechanism. We attributed this moderate
β-catenin activity in BE to the subsequent overexpression of the Wnt
target gene Dkk1. It is known that Dkk1 protein suppresses the Wnt
signaling by antagonizing the binding of canonical Wnts to LRP5/6
receptors in a negative feedback loop [22]. The increased signaling
608 Wnt-Signaling Activation in Barrett’s metaplasia Lyros et al. Neoplasia Vol. 17, No. 7, 2015activation of β-catenin by Wnt3a was blocked by Dkk1, whereas
Dkk1 knockdown in CP-A cells resulted in increased β-catenin
transcriptional activity along with a higher sensitization of the cells to
Wnt3a. Taken together, these observations suggest a Dkk1-mediated
suppression of Wnt-induced β-catenin activation in BE and allow us
to propose a model of a closed circuit of Wnt signaling regulation in
BE metaplasia, which aims to sustain the β-catenin activity to certain
low levels. The secreted endogenous Wnt3a activates the canonical
signaling, resulting downstream to Dkk1 gene increased transcription
and subsequently to elevated Dkk1 protein secretion, which in turn
counteracts an excessive Wnt3a receptor binding (Figure 8). This
proposed model explains the positive AXIN2 and Dkk1 expression
observed in the basal high proliferative layer of the normal squamous4
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intestinal metaplasia [20,39]. In the light of our current findings,
Wnt/β-catenin signaling pathway appears moderately activated in BE
metaplasia. One way in which Wnt signaling could contribute to the
columnar differentiation is through activation of BMP signaling.
BMP4 signaling was reduced in a mouse model following deletion of
Wnt ligands [40], suggesting that Wnt signaling may be positioned
upstream of BMP pathway in specifying the columnar differentiation.
In line with this conclusion, the stimulation of CP-A cells with
recombinant Wnt3a upregulated the BMP gene expression (unpub-
lished data, Lyros). However, it needs to be examined whether
β-catenin activity at the levels detected in BE is sufficient for the
induction and/or maintenance of intestinal BE metaplasia.
The current theories on the origin of BE include a direct origin from
the esophageal-stratified squamous epithelium or proximal migration of
the gastric cardiac epithelium with subsequent intestinalization. Recent
evidence supports that Barrett glands, although unique structures, share
many similarities with gastric glands undergoing intestinalization,
supporting an origin from stem cells in the cardia [41]. By showing a
relatively lower AXIN2 protein expression in gastricmucosa than in BE,
we can speculate that activation of Wnt signaling in BE might dictate
the intestinal phenotype of the migrating stem cells of the cardia, rather
than being a gastric tissue characteristic. However, a more comprehen-
sive study on Wnt gene profiling between BE metaplasia and gastric
mucosa is required to define whether Wnt signaling activation
characterizes only BE metaplasia.
On the orther hand, Wnt signaling appears to be an important
driver of BE malignant transformation. Previous reports implicate a
progressive increase of Wnt signaling in the metaplasia–dysplasia–
carcinoma sequence of BE [9,11,42]. In an effort to elucidate this
activation, changes, such as increased expression of Wnt2 ligand or
epigenetic loss of the Wnt inhibitory factor 1 and secreted frizzled
receptor proteins negative regulators, have already been reported in
EAC [10,13,14]. However, the trigger for the aberrant β-catenin
signaling activation in BE toward dysplasia remains largely unknown.
Interestingly, loss-of-function mutations in APC, β-catenin, or Axin,
which have been associated with high β-catenin activity [43], are not
frequently detected in BE or EAC [12]. Thus, the identification of
Dkk1 as signaling suppressor in BE metaplasia, but not in EAC, may
suggest a significant mechanism of esophageal tumorigenesis. In fact,
not all patients with BE will finally develop EAC, indicating that even
the metaplastic mucosa reserves host defense in order to reverse signal
transduction and prevent carcinogenesis. Thus, Dkk1 could serve as
such host defense against further Wnt activation in BE metaplasia and
its loss of function to induce malignant transformation. Intriguingly,
Dkk1 is found to be overexpressed in EAC [24], while, at the same
time, β-catenin activity is also significantly elevated, indicating high
possibility of a defect within Dkk1 negative feedback loop caused
either by posttranscriptional Dkk1 loss of function or by aberrant
signaling activation downstream of the Dkk1 site of action. Further
investigations testing these scenarios in BE-associated dysplasia and
EAC are currently ongoing.
An acknowledged limitation of this study is that, despite a
moderate level of activation, the role of β-catenin signaling in BE
initiation remains questionable. In view of our findings, Wnt
signaling can play an important role in BE development as opposed to
the current belief. Although speculative, several observations favor this
hypothesis, including the overexpression of CyclinD1 and c-MYCbeforedysplasia even occurs [16,17] and the transcriptional regulation of
intestinal markers by β-catenin activity [18,19], along with the efficiency
of Wnt signaling to intestinalize human esophageal keratinocytes in vitro
[20]. Undoubtedly, our study compliments these observations and brings
the issue of Wnt signaling back in the forefront of BE pathogenesis. A
second limitation is the doubtful role of AXIN2 overexpression in
regulating theWnt-axis in BE and EAC. Given its suppressive features as
a main component of the β-catenin destruction complex [44], AXIN2
could also suppress β-catenin activity downstream of Wnt-receptor
binding. This scenario could highlight a multistage suppression of
Wntaxis in BEmetaplasia and as such further justify amoderate β-catenin
activity, whereas, in EAC, it could indicate that the aberrant β-catenin
signaling activation either originates downstream of the AXIN2 site of
action or is even Wnt axis independent. These attractive scenarios are
speculative and merit further investigation.
In conclusion, we define a moderate β-catenin signaling activation
in BE metaplasia, compared with squamous esophageal mucosa,
capsizing the current view in which β-catenin is transcriptionally
inactive in BE metaplasia based on the absence of its robust nuclear
accumulation. We attribute this moderate state of signaling activation
to the subsequent overexpression of the Wnt target gene Dkk1, which
counteracts Wnt signals in a negative feedback loop. Intriguingly,
similar Dkk1-mediated signaling suppression was not evident in
adenocarcinoma cells, signifying that early perturbation of
Dkk1-mediated signaling suppression might be responsible for
neoplastic progression. Although it remains unclear if this moderate
β-catenin activity is responsible for BE development, our findings
point to its significance with respect to BE malignant transformation
and emphasize the need of further studies regarding Wnt signaling in
esophageal tumorigenesis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neo.2015.07.006.
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